SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTER-DEALER QUOTATION SYSTEM FILED PURSUANT TO
SECTION 13 OR 15(D) OR THE SECURITIES EXCHANGE ACT
OF 1934 AND RULES 13A-17 AND 15D-17 THEREUNDER
HealthWatch, Inc.
(Exact Name of Issuer as Specified in Charter)
2445 Cades Way, Vista, California 92083
(Address of Principal Executive Offices)
(619) 598-4333
(Issuer's Telephone Number, Including Area Code)
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:
1. Title of security COMMON STOCK $.01 PAR VALUE
2. Number of shares outstanding before the change 7,782,779 SHS.
(AS OF 9/30/95)
3. Number of shares outstanding after the change 9,010,153 SHS.
4. Effective date of change OCTOBER 6, 1995-FEBRUARY 16, 1996
5. Method of change: ISSUANCE OF STOCK IN CONNECTION WITH
PAYMENT FOR SERVICES AND ACCOUNTS
PAYABLE AND UPON EXERCISE OF STOCK
PURCHASE WARRANTS.
Give brief description of transaction: During the period from October
6, 1995 through February 16, 1996, the Company issued an aggregate of 1,227,374
shares of its common stock pursuant to the exercise of outstanding stock
purchase warrants (702,000 shares at $.30 per share and 360,000 shares at $.25
per share), payment of trade accounts payable (152,674 shares) and payment of
consulting services and employee bonuses (12,700 shares).
I. CHANGE IN NAME OF ISSUER
(Not applicable)
Date February 22, 1996 /s/ Annette D. Agner
Annette D. Agner
Chief Financial Officer
GP:264620 v1
